← Every company

Madrigal Pharmaceuticals Inc SEC Filings

What Madrigal Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

MDGL overview →
Filings on file
124
since Sep 30, 2016
Warning signs
2
latest Mar 31, 2017
Last results
Jul 30, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Aug 12, 2026
Executive or director change
8-K
Read ↗
Jun 17, 2026
Executive or director changeShareholder vote
8-K
Read ↗
Apr 28, 2026
Executive or director change
8-K
Read ↗
Dec 11, 2025
Executive or director change
8-K
Read ↗
Apr 17, 2025
Executive or director change
8-K
Read ↗
Mar 11, 2025
Executive or director change
8-K
Read ↗
Jun 27, 2024
Executive or director changeShareholder vote
8-K
Read ↗
Feb 28, 2024
Executive or director change
8-K
Read ↗
Sep 25, 2023
Executive or director change
8-K
Read ↗
Sep 14, 2023
Executive or director change
8-K
Read ↗
Sep 13, 2023
Executive or director change
8-K
Read ↗
Jun 20, 2023
Executive or director change
8-K
Read ↗
Jun 21, 2021
Executive or director changeShareholder vote
8-K
Read ↗
May 18, 2021
Executive or director change
8-K
Read ↗
Jul 11, 2019
Executive or director change
8-K
Read ↗
Jul 2, 2019
Executive or director changeShareholder vote
8-K
Read ↗
Jul 5, 2017
Executive or director changeShareholder vote
8-K
Read ↗

Source: Madrigal Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on MDGL

Related datasets